logo
Select company
Select metric
33.66%Capital Expenditures to Operating Cash Flow
VS
Market
42
Sector
34
Industry
36
History
5
$ 15.5Close
$ 12.02 - $ 16.47 52-Week Range
Ticker Information

Ticker

FONR

Company Name

FONAR CORP

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

FONAR CORP - Capital Expenditures to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FONR - CapEx/OCF Historical data
DateCapital ExpenditureCapital Expenditures to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ 3.79M33.66%$ 11.26M
3/31/2025$ 3.56M30.58%$ 11.64M
12/31/2024$ 3.15M27.87%$ 11.3M
9/30/2024$ 2.53M19.28%$ 13.13M
6/30/2024$ 789.96K5.61%$ 14.09M
3/31/2024$ 1.04M7.53%$ 13.81M
12/31/2023$ 3.05M19.93%$ 15.29M
9/30/2023$ 3.34M23.23%$ 14.39M
6/30/2023$ 4.22M29.16%$ 14.47M
3/31/2023$ 4.29M27.99%$ 15.33M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FONAR CORP's latest trailing twelve months (TTM) CapEx/OCF stands at 27.72%.
  • Over the past 5 years, FONAR CORP's average CapEx/OCF has been 24.9%.
  • The median CapEx/OCF for FONAR CORP during this period was 26.53%
  • FONAR CORP reached its highest CapEx/OCF over the past 5 years at 33.66%.
  • The lowest CapEx/OCF recorded by FONAR CORP in the same timeframe 5.61%

FONAR CORP's CapEx/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx/OCF Benchmarks
CompanyCapEx/OCF
BDSX : BIODESIX INC -CCLD : CARECLOUD INC 29.81%ANIK : ANIKA THERAPEUTICS INC 118.08%STRO : SUTRO BIOPHARMA INC -XTNT : XTANT MEDICAL HOLDINGS INC 268.89%AGEN : AGENUS INC -CHRS : COHERUS ONCOLOGY INC -RCEL : AVITA MEDICAL INC -ASRT : ASSERTIO HOLDINGS INC -SERA : SERA PROGNOSTICS INC -

Definition of Capital Expenditures to Operating Cash Flow

[Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for FONAR CORP is calculated as follows: CapEx [ $ 5.53M ] / CF - Operations [ $ 19.94M ]
(=) CapEx/OCF [ 27.72% ]

FONR - Capital Expenditures to Operating Cash Flow, Last 5 years

5.61%

Minimum

Jun 30, 2024

33.66%

Maximum

Jun 30, 2025

24.9%

Average

26.53%

Median

CapEx/OCF Benchmark Analysis

The chart above depicts the distribution of CapEx/OCF for companies in the Total Stock Market. The average CapEx/OCF of the companies is 31.82% with a standard deviation of 29.54%.
The following table provides additional summary stats:
CapEx/OCF in the Market:
filtered constituents2.35K
min0.01%
max128%
average31.82%
median22.41%
std29.54%